OpenLegislation

Division 2.3.1 Supporting key Community strategies on addictive substances

United Kingdom

Original text. Later amendments are not shown.

  1. (1)

    In support of further developing the work on tobacco, projects proposals should focus on:

    • Mapping, assessment evaluation and dissemination of recent developments and best practice in tobacco control in the Member States, targeting in particular young people and women; communication strategies for prevention and cessation and addressing socio-economic aspects;

    • Develop and network prevention and cessation activities, focusing on innovative approaches to denormalisation and on reducing exposure to tobacco smoke;

    • Other EU and internal activities to implement requirements derived from the Framework Convention on Tobacco Controlf1, such as work on tobacco ingredients, surveillance or illicit trade in tobacco products.

  2. (2)

    On alcohol, activities will be linked to the overall strategic approach to reducing alcohol-related harm. The priority will be to support networking that brings together a coordinated and comprehensive range of activities in fields such as research, information, consumer protection, transport, commercial communications and other internal market issues, drawing on country-based experiences. This could involve inter alia:

    • Developing an inventory and monitoring of country-based experiences;

    • Economic and health impact assessments of different policy options;

    • Capacity building for effective programme and policy implementation.

  3. (3)

    On drugs, in line with the EU Drugs Strategyf2 and Action Planf3 and the Council Recommendation on Drugsf4, priority will be given to proposals on:

    • Harm reduction responses to emerging trends related to psychoactive substances with a focus on ecstasy, crack/cocaine and cannabis use;

    • Development or improvement and implementation of joint prevention programmes in public services, education and relevant NGOs focusing on socially disadvantaged groups;

    • An inventory of good practice on drug treatment and its effects, covering also reintegration, to follow-up actions set out in the Action Plan.

Annotations

Footnotes

f1

Council Decision No 2004/513/EC of 2 June 2004 concerning the conclusion of the WHO Framework Convention on Tobacco Control (OJ L 213, 15.6.2004, p. 8).

f2

EU Drugs Strategy [2005-2012]. See http://europa.eu.int/comm/health/ph_determinants/life_style/keydo_drug_en.htm

f3

EU Action Plan on Drugs [2005-2008]. See http://europa.eu.int/comm/health/ph_determinants/life_style/keydo_drug_en.htm

f4

Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence (OJ L 165, 3.7.2003, p. 31).

Notes on Division 2

Footnotes

f1

Decision No 1513/2002/EC of the European Parliament and of the Council of 27 June 2002 (OJ L 232, 29.8.2002, p. 1).

f2

Refer also to FP6 Scientific Support to Policies, 5th Call, SSP-5A Areas 2.1 & 2.2.

See: http://fp6.cordis.lu/index.cfm?fuseaction=UserSite.FP6ActivityCallsPage&ID_ACTIVITY=500

f3

Council Decision 2002/834/EC of 30 September 2002 adopting a specific programme for research, technological development and demonstration ‘Integrating and Strengthening the European Research Area’ (2002-2006) (OJ L 294, 29.10.2002, p. 1).

f4

The CORDIS web site links to the FP6 Priority 1 is http://www.cordis.lu/lifescihealth/ssp.htm